noDNA | Updates
This investment carries considerable risks and may lead to a complete loss of the capital invested. More
By Robert Dotzauer

noDNA Sees Record Sales in August

Public
Public

 

Dear Companists,

First, we would like to thank you for your confidence! Within no time, we reached the investment threshold of €100,000, which proves that we are on the right track.

 

Record Sales in August 2015

There is also great news on our business. For the first time since Robert Dotzauer took over as managing director of noDNA, we sent invoices totaling more than €100,000 to our customers in August 2015. A major part of these revenues was due to the University of Manchester, an important customer of ours that will hopefully provide us with good business opportunities in the future.

We are really pleased not only because revenues in August surpassed our projections by more than 70 %, but also because we expect revenues in 2015 to increase by 10-15 % compared to our projections.

 

Best regards,
The noDNA team



Comments

Only registered Companists can comment. Please log in to leave a comment.

NOTE:

Investments in crowdfunding projects offer great opportunities, but they are risk investments. In the worst case, the entire investment amount may be lost. Consequently, these investments are unsuitable for retirement plans. However, there is no obligation to make further contributions. Investors can minimize their risk by splitting their investment amount between crowdfunding campaigns rather than investing all of it in one crowdfunding campaign. Professional investors often follow this strategy because it causes the risk to be distributed among several investments. In this way, successful investments can balance other less successful investments.

The shares of the Companists are subordinated profit-participating loans (partiarische Nachrangdarlehen). Such loans are shares in a business with similar characteristics as equity. If the company becomes insolvent or is liquidated, the claims of the Companists – just like those of all other shareholders of the company – will be satisfied from the assets in the insolvency or the assets in liquidation only after the claims of all other external creditors have been satisfied. Thus, Companists are treated like any other shareholder of the company during insolvency or liquidation proceedings.

The company information published on the Companisto website is provided solely by the companies. The projections made by the companies do not guarantee successful development of the company in the future. Consequently, crowdfunding investments are suitable only for those investors who can cope with the risk of a total loss of the capital invested. Investors make their own independent investment decisions and bear all risks themselves.

The investments are provided and issued by the individual companies. Companisto is neither the provider nor the issuer of the investments, but solely the internet service platform.

581

Companists

406,115 €

Invested

8%

p.a. annual interest

Data
8.00% p.a.

Fixed Interest Rate

30 Sep. 2019

Maturity Date

semi-annual

Interest Payments

Contact Details
noDNA GmbH
Gutenbergstr. 1
85737 Ismaning
Germany

Email: investor-relations@nodna.de
Website: www.nodna.de
Please note
The acquisition of this asset involves considerable risks and can lead to the complete loss of the assets used.

Follow us

Contact Us
Your contact for all questions about investing on Companisto:
Andreas Riedel
Investor Relations

Toll-free phone number for investors

0800 - 100 26 70 (DE)
0800 - 10 02 67 (AT)
0800 - 10 02 67 (CH)

Service hours Mo-Fr 9 a.m.- 7 p.m.

Companisto GmbH
Köpenicker Str. 154
10997 Berlin
TÜV geprüftes Online-Portal | Companisto
Source: Own research. Based on data from the German Private Equity and Venture Capital Association - BVK, among others.
Investor Support